N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity

DNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially thr...

Full description

Bibliographic Details
Main Authors: Sara B. Fernandes, Nathalie Grova, Sarah Roth, Radu Corneliu Duca, Lode Godderis, Pauline Guebels, Sophie B. Mériaux, Andrew I. Lumley, Pascaline Bouillaud-Kremarik, Isabelle Ernens, Yvan Devaux, Henri Schroeder, Jonathan D. Turner
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/full
id doaj-5d2ad1c45d704d998e841fab3b44a220
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Sara B. Fernandes
Sara B. Fernandes
Nathalie Grova
Nathalie Grova
Sarah Roth
Radu Corneliu Duca
Radu Corneliu Duca
Lode Godderis
Lode Godderis
Pauline Guebels
Sophie B. Mériaux
Andrew I. Lumley
Pascaline Bouillaud-Kremarik
Isabelle Ernens
Yvan Devaux
Henri Schroeder
Jonathan D. Turner
spellingShingle Sara B. Fernandes
Sara B. Fernandes
Nathalie Grova
Nathalie Grova
Sarah Roth
Radu Corneliu Duca
Radu Corneliu Duca
Lode Godderis
Lode Godderis
Pauline Guebels
Sophie B. Mériaux
Andrew I. Lumley
Pascaline Bouillaud-Kremarik
Isabelle Ernens
Yvan Devaux
Henri Schroeder
Jonathan D. Turner
N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
Frontiers in Genetics
DNA methylation
6-methyladenine
embryo development
developmental neurotoxicity
stress
brain
author_facet Sara B. Fernandes
Sara B. Fernandes
Nathalie Grova
Nathalie Grova
Sarah Roth
Radu Corneliu Duca
Radu Corneliu Duca
Lode Godderis
Lode Godderis
Pauline Guebels
Sophie B. Mériaux
Andrew I. Lumley
Pascaline Bouillaud-Kremarik
Isabelle Ernens
Yvan Devaux
Henri Schroeder
Jonathan D. Turner
author_sort Sara B. Fernandes
title N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
title_short N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
title_full N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
title_fullStr N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
title_full_unstemmed N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity
title_sort n6-methyladenine in eukaryotic dna: tissue distribution, early embryo development, and neuronal toxicity
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2021-05-01
description DNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially through 5-methylcytosine (5mC) but recently adenine methylation was also found to be present in eukaryotes. In mouse embryonic stem cells, 6-methyladenine (6mA) was associated with the repression and silencing of genes, particularly in the X-chromosome, known to play an important role in cell fate determination. Here, we have demonstrated that 6mA is a ubiquitous eukaryotic epigenetic modification that is put in place during epigenetically sensitive periods such as embryogenesis and fetal development. In somatic cells there are clear tissue specificity in 6mA levels, with the highest 6mA levels being observed in the brain. In zebrafish, during the first 120 h of embryo development, from a single pluripotent cell to an almost fully formed individual, 6mA levels steadily increase. An identical pattern was observed over embryonic days 7–21 in the mouse. Furthermore, exposure to a neurotoxic environmental pollutant during the same early life period may led to a decrease in the levels of this modification in female rats. The identification of the periods during which 6mA epigenetic marks are put in place increases our understanding of this mammalian epigenetic modification, and raises the possibility that it may be associated with developmental processes.
topic DNA methylation
6-methyladenine
embryo development
developmental neurotoxicity
stress
brain
url https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/full
work_keys_str_mv AT sarabfernandes n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT sarabfernandes n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT nathaliegrova n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT nathaliegrova n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT sarahroth n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT raducorneliuduca n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT raducorneliuduca n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT lodegodderis n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT lodegodderis n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT paulineguebels n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT sophiebmeriaux n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT andrewilumley n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT pascalinebouillaudkremarik n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT isabelleernens n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT yvandevaux n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT henrischroeder n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
AT jonathandturner n6methyladenineineukaryoticdnatissuedistributionearlyembryodevelopmentandneuronaltoxicity
_version_ 1721428767818121216
spelling doaj-5d2ad1c45d704d998e841fab3b44a2202021-05-24T06:13:30ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-05-011210.3389/fgene.2021.657171657171N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal ToxicitySara B. Fernandes0Sara B. Fernandes1Nathalie Grova2Nathalie Grova3Sarah Roth4Radu Corneliu Duca5Radu Corneliu Duca6Lode Godderis7Lode Godderis8Pauline Guebels9Sophie B. Mériaux10Andrew I. Lumley11Pascaline Bouillaud-Kremarik12Isabelle Ernens13Yvan Devaux14Henri Schroeder15Jonathan D. Turner16Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgFaculty of Science, Technology and Medicine, University of Luxembourg, Belval, LuxembourgImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgUnit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, National Health Laboratory (LNS), Dudelange, LuxembourgCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, BelgiumCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, BelgiumIDEWE, External Service for Prevention and Protection at Work, Heverlee, BelgiumImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, LuxembourgCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, FranceImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, LuxembourgDNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially through 5-methylcytosine (5mC) but recently adenine methylation was also found to be present in eukaryotes. In mouse embryonic stem cells, 6-methyladenine (6mA) was associated with the repression and silencing of genes, particularly in the X-chromosome, known to play an important role in cell fate determination. Here, we have demonstrated that 6mA is a ubiquitous eukaryotic epigenetic modification that is put in place during epigenetically sensitive periods such as embryogenesis and fetal development. In somatic cells there are clear tissue specificity in 6mA levels, with the highest 6mA levels being observed in the brain. In zebrafish, during the first 120 h of embryo development, from a single pluripotent cell to an almost fully formed individual, 6mA levels steadily increase. An identical pattern was observed over embryonic days 7–21 in the mouse. Furthermore, exposure to a neurotoxic environmental pollutant during the same early life period may led to a decrease in the levels of this modification in female rats. The identification of the periods during which 6mA epigenetic marks are put in place increases our understanding of this mammalian epigenetic modification, and raises the possibility that it may be associated with developmental processes.https://www.frontiersin.org/articles/10.3389/fgene.2021.657171/fullDNA methylation6-methyladenineembryo developmentdevelopmental neurotoxicitystressbrain